Basit öğe kaydını göster

dc.contributor.authorPoyraz, Cana Aksoy
dc.contributor.authorBenbir, Gulcin
dc.contributor.authorApaydin, Hulya
dc.date.accessioned2021-03-03T09:46:14Z
dc.date.available2021-03-03T09:46:14Z
dc.date.issued2014
dc.identifier.citationBenbir G., Poyraz C. A. , Apaydin H., "DIAGNOSTIC APPROACH TO BEHAVIORAL OR "NON-SUBSTANCE" ADDICTIONS", NOBEL MEDICUS, cilt.10, sa.1, ss.5-11, 2014
dc.identifier.issn1305-2381
dc.identifier.othervv_1032021
dc.identifier.otherav_1ed11560-1713-4824-ad2c-22cf4e8f4806
dc.identifier.urihttp://hdl.handle.net/20.500.12627/25859
dc.description.abstractUntil recently, non-substance related behavioral addictions were not categorized in diagnostic manuals of mental disorders. Addictive states are characterized by changed reinforcement contingencies, anhedonia, diminished capacity to experience pleasures due to reduced sensitivity to endogenous brain dopamine, and increased sensitivity to internal and external triggering factors. An underlying biological mechanism for urge-driven disorders may involve the pre-frontal cortex, nucleus accumbens, the ventral tegmental area, amygdala and hippocampus, which are considered to play a critical role in the characteristic behavioral impairments of addictive disorders. Recent literature implicates serotonergic, dopaminergic, noradrenergic, and opioidergic neurotransmitter systems in the pathophysiology of behavioral addictions. A reduction in the sensitivity of the brain reward system and hyperactivity towards addiction-associated stimuli was demonstrated in addiction disorders. Due to the lack of a diagnostic guide, different psychometric instruments were used to assess behavioral addictions, including pathological gambling, compulsive buying, internet addiction, video/computer game addiction, sexual addiction, and excessive tanning. Psychosocial interventions encourage the abstinence by lifestyle changes, and reinforce healthy behaviors via motivational enhancement and cognitive behavioral therapies. Pharmacologically, there are no medications currently approved for the treatment of behavioral addictions, but naltrexone, topiramate, and N-acerylcysteine have some promising effects.
dc.language.isoeng
dc.subjectTıp
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTemel Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.titleDIAGNOSTIC APPROACH TO BEHAVIORAL OR "NON-SUBSTANCE" ADDICTIONS
dc.typeMakale
dc.relation.journalNOBEL MEDICUS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume10
dc.identifier.issue1
dc.identifier.startpage5
dc.identifier.endpage11
dc.contributor.firstauthorID22030


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster